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a  b  s  t  r  a  c  t
Foot-and-mouth  disease  virus  (FMDV)  is  a signiﬁcant  economically  and  distributed  globally  pathogen  of
Artiodactyla.  Current  vaccines  are  chemically  inactivated  whole  virus  particles  that  require  large-scale
virus  growth  in  strict  bio-containment  with  the  associated  risks  of  accidental  release  or incomplete  inac-
tivation.  Non-infectious  empty  capsids  are  structural  mimics  of authentic  particles  with  no  associated
risk  and  constitute  an  alternate  vaccine  candidate.  Capsids  self-assemble  from  the  processed  virus  struc-
tural proteins,  VP0,  VP3  and VP1,  which  are  released  from  the  structural  protein  precursor  P1-2A  by  the
action of  the  virus-encoded  3C protease.  To  date  recombinant  empty  capsid  assembly  has  been  limited  by
poor expression  levels,  restricting  the  development  of  empty  capsids  as  a  viable  vaccine.  Here  expression
of the  FMDV  structural  protein  precursor  P1-2A  in  insect  cells  is shown  to  be efﬁcient  but  linkage  of  the
cognate  3C  protease  to  the  C-terminus  reduces  expression  signiﬁcantly.  Inactivation  of  the  3C enzyme  in  a
P1-2A-3C  cassette  allows  expression  and  intermediate  levels  of  3C  activity  resulted  in efﬁcient  processing
of  the  P1-2A  precursor  into  the  structural  proteins  which  assembled  into  empty  capsids.  Expression  was
independent  of the  insect  host  cell  background  and  leads  to  capsids  that  are  recognised  as  authentic  by
a range  of  anti-FMDV  bovine  sera  suggesting  their  feasibility  as an  alternate  vaccine.
© 2012 Elsevier B.V. All rights reserved.
1. Introduction
Foot-and-mouth disease virus (FMDV) is the prototypic aph-
thovirus within the family Picornaviridae (reviewed by (Grubman
and Baxt, 2004)). Economic losses from foot-and-mouth disease
outbreaks are among the highest of all livestock diseases and
widespread vaccination is the method of choice for disease con-
trol (Rodriguez and Grubman, 2009). The current vaccine is a killed
whole virus vaccine whose limitations have been widely discussed;
growth of the live virus prior to inactivation is not without risk,
the appropriate serotype for each outbreak is required, some ﬁeld
strains grow poorly before adaptation and immunogenicity can be
∗ Corresponding author.
E-mail addresses: i.m.jones@rdg.ac.uk, i.m.jones@reading.ac.uk (I.M. Jones).
lost upon storage (Rodriguez and Grubman, 2009). To address these
issues alternate vaccines have been sought, among them the use of
empty capsids which are structural and immunogenic mimics of
virus particles but lack the potential for causing disease outbreak
(Rowlands et al., 1975; Rweyemamu et al., 1979).
As for all picornaviruses, the icosahedral FMDV capsid is assem-
bled from mature proteins derived from a structural precursor,
P1-2A, following cleavage in trans by the 3C protease (reviewed by
(Belsham, 2005)). The 3C protease is one of many non-structural
proteins synthesised in the infected cell but expression of P1-
2A and 3C in the absence of any other FMDV encoded protein
in recombinant systems is sufﬁcient to afford authentic precur-
sor cleavage (Lewis et al., 1991; Roosien et al., 1990). Accordingly
there have been a number of reports of the assembly of recombi-
nant FMDV empty capsids following the use of expression systems
such as vaccinia virus (Abrams et al., 1995), adenovirus (Mason
0166-0934/$ – see front matter ©  2012 Elsevier B.V. All rights reserved.
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et al., 2003), E. coli (Cao et al., 2010; Lewis et al., 1991), transgenic
plants (Pan et al., 2008) and baculovirus (Li et al., 2008; Oem et al.,
2007; Roosien et al., 1990). In some cases, sufﬁcient empty cap-
sid material has been prepared to immunise cattle and protection
against homologous challenge was demonstrated (Li et al., 2008,
2011) but in the main the conﬁguration of the P1and 3C coding
sequences used to achieve empty capsid expression and the efﬁ-
ciency of capsid assembly has been highly variable, particularly in
insect cells. For example, using the successful expression of swine
vesicular disease empty capsids as an exemplar (Ko et al., 2005),
usage of a dual promoter vector in which the P1 and 3C coding
sequences of an O serotype of FMDV were under the control of the
baculovirus polyhedrin and p10 promoters respectively, resulted
in incomplete precursor cleavage and predominantly pentameric
assemblies rather than complete capsids (Oem et al., 2007). Simi-
larly, a dual expression strategy of an Asia 1 serotype of FMDV led
to incomplete cleavage of the P1-2A precursor (Cao et al., 2009).
More recently, forsaking the use of 3C to generate the mature cap-
sid proteins, VP0 and VP3-2A-VP1 from an O serotype of FMDV
were co-expressed relying on self-cleavage at the 2A site (Donnelly
et al., 2001) to generate the requisite structural proteins for assem-
bly, which resulted in partial success (Cao et al., 2010). In a further
example, a Bombyx (silk worm) baculovirus system encoding a
P1-2A-3C sequence of an FMDV Asia 1 isolate was used as a sin-
gle transcription unit driven by the polyhedrin promoter and the
empty capsid material harvested from the haemolymph of the
infected silk worms was immunogenic in cattle and led to lev-
els of neutralising antibody associated with protection (Li et al.,
2008, 2011). Despite these successes, variation associated with
both the FMDV serotype and the host cell background used mean
that a uniform genetic design capable of producing empty cap-
sids for any serotype has yet to be reported. Recently, the yield
of empty capsids from insect cells for another picornavirus, human
enterovirus 71, was improved by use of a dual vector in which a less
active promoter, the CMV  early promoter, was used for transcrip-
tion of the 3C coding unit whilst the strong polyhedrin promoter
directed expression of the P1 structural precursor (Chung et al.,
2010). However, yield improvement was restricted to Sf9 cells as
infection of T.ni cells, an alternative insect cell line that generally
gives higher expression levels (Davis et al., 1993), resulted in poor
capsid expression plausibly as a result of low levels of promoter-
speciﬁc transcription factors present in T.ni cells. Picornaviruses
traditionally exhibit a strong “host cell shutoff” phenotype which
is partly the result of 3C protease cleavage of host cell proteins in
addition to its action on the virus structural precursor P1 (Li et al.,
2001; Strong and Belsham, 2004). As a result, picornavirus repli-
cation cycles are typically rapid and exhibit extensive cytopathic
effect (e.g. (Rodriguez Pulido et al., 2007)). It follows that if cleav-
age of host cell proteins by FMDV 3C protease was  to occur in a
recombinant empty capsid expression system it would curtail the
expression period and limit the yield of capsids observed. Thus,
variable levels of 3C expression could account for the variation in
the levels of FMDV empty capsids reported to date and purpose-
ful moderation of 3C activity might enhance the yield of capsid
observed, allowing a more thorough exploration of their virtues
as vaccine candidates. Here a new genetic design is described for
the expression of empty FMDV capsids in insect cells following
infection by recombinant baculoviruses expressing P1-2A-3C with
a number of modiﬁcations to reduce 3C activity.
2. Materials and methods
2.1. Cell culture and virus growth
Sf9, T.ni and T.nao38 cells were cultured in BioWhittaker®
Insect-Xpress (Lonza, Basel, Switzerland) supplemented with 2%
FCS, 100 units/ml penicillin, 100 g/ml streptomycin and 2.5 g/ml
amphotericin B. Cells were grown at 28 ◦C as monolayers or in sus-
pension with agitation at 100 rpm. Baculoviruses were generally
ampliﬁed in monolayer cultures but large scale infections for cap-
sid isolation were done in suspension. Virus stocks were titreed
using plaque assay on Sf9 monolayers.
2.2. Sequences and cloning
The sequence for FMDV A22 Iraq (AY593764.1) was that
deposited in the database. DNA was  synthesised de novo (Lifetech-
nologies, Carlsbad, USA). The transfer vector used for all expressions
was  based on pOPINE (Berrow et al., 2007), itself a derivative of
pTriEx1.1 (EMD Biosciences, Billerica, USA) and a fragment encod-
ing P1-2A-3C of FMDV serotype A22 was  cloned downstream of the
p10 promoter by use of In-Fusion Technology (Clontech, Moun-
tain View, USA). Mutations within this cassette were introduced
by the swapping of appropriate fragments via unique restriction
sites introduced during gene synthesis. Recombination between
pOPINE vectors and AcMNPV bacmid KO1629 in insect cells was
as described (Zhao et al., 2003). Routine DNA procedures in vitro
made use of standard protocols or, when kits were used, those
recommended by the vendor. All vectors were conﬁrmed by DNA
sequencing prior to use for expression.
Fig. 1. Expression screening of various FMDV P1-2A ± 3C cassettes. (A) Cartoon rep-
resentation of the genetic designs tested. The text near the bottom right represents
the amino acid sequence of FMDV 3C between residues 141–170 with Cys 142 and
Cys  163 highlighted. (B) Outcome of screening the various A22 Iraq constructs by
immunoblotting using a polyvalent A serum. The expected migration positions of P1-
2A-3C, P1-2A and VP1 are indicated although very little P1-2A-3C is visible. Numbers
to the left are the migration positions of protein markers and are in kilodaltons.
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2.3. Electrophoresis and Western blotting
Protein samples were separated on pre-cast 10% Tris–HCl SDS-
polyacrylamide gels (BioRad, Berkeley, USA) and transferred to
Immobilon-P membranes (Millipore, Billerica, USA) using a semi-
dry blotter. For 10-well gels each sample loaded represented
5 × 104 cells. Following transfer, ﬁlters were blocked for 1 h at room
temperature using PBS containing 0.1% v/v Tween-20 (PBS-T), 5%
w/v milk powder. Primary antibodies were used at 1 g/ml or at a
dilution of 1:1000 in PBS-T, 5% w/v milk powder. Following several
washes with PBS-T, the membranes were incubated for 1 h with the
appropriate HRP-conjugates and the bound antibodies detected by
BM chemiluminescence (Roche, Basel, Switzerland).
2.4. Puriﬁcation of empty capsids
Infected cultures (typically ∼109 cells) were harvested at 3 days
pi. and lysed by resuspension in 1/20th of the original volume of
1% Triton X-100 in PBS and held at 4 ◦C for 30 min  with occasional
agitation. Unbroken cells and nuclei were removed by centrifuga-
tion (4500 rpm, 15 min) and the clariﬁed lysate layered onto a 30%
sucrose (w/v in PBS) cushion. After centrifugation at 100,000 × g for
100 min  the supernatant was  discarded and the pellet resuspended
in 1/10 tube volume of PBS containing 3500 units of benzonase.
After 30 min  at room temperature, the solution was  clariﬁed and
applied to a preformed discontinuous 30–60% sucrose (w/v in PBS)
gradient made up by seven increments of 5%. The gradient was
developed by centrifugation at 100,000 × g for 16 h and fractionated
from the top.
2.5. Assessing capsid antigenicity
Assays to measure the reactivity of recombinant empty cap-
sids with a range of FMDV serotype speciﬁc polyclonal antisera
were performed in a competitive ELISA format as described (Li
et al., 2012). Data were expressed as percentage inhibition scores
compared to an OIE standard antigen preparation. Statistical sig-
niﬁcance was assessed by one-way analysis of variance (ANOVA).
Fig. 2. Cartoon representation of the vector used for expression of empty FMDV capsids with the salient features shown. Unique restriction sites available for the exchange
of  the capsid polyprotein precursor coding region from different serotypes are indicated by red boxes. (B) Translated ORF details of the P1-2A polyprotein, the 3C protease
and  the junctions between them. The frameshift event, which begins on the overlapping Phe residue and results in a single polyprotein linking the P1-2A and 3C proteins, is
indicated by the dotted line. (C) Sequence detail of the HIV frameshift (above) and its relationship to the translated product (below).
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2.6. Electron microscopy
Samples were allowed to adhere to carbon coated formvar grids
for 5 min  at room temperature followed by a brief water wash
(1 min) before staining with 1% uranyl acetate for 1 min. Excess
stain was removed by blotting and the grids examined on a Philips
CM20 (Philips Electronics, Amsterdam, Netherlands) operating at
80 kV.
3. Results
Preliminary experiments with constructs (Fig. 1A) encoding the
previously deﬁned minimum proteins for FMDV capsid protein
expression and cleavage (Lewis et al., 1991; Roosien et al., 1990)
based on a synthetic sequence of FMDV A22 Iraq revealed that
expression of P1-2A led to the abundant synthesis of FMDV-related
antigen of the expected molecular weight (∼90 kDa) as well as some
non-speciﬁc degradation products, whilst fusion of 3C in phase with
the C terminus of P1-2A effectively abolished expression (Fig. 1B).
When the same expression cassette included a site-directed change
of the 3C active site cysteine 163 to alanine (Sweeney et al., 2007),
expression of a protein of the molecular weight of P1-2A fused to
3C (a minor product) in addition to P1-2A (the predominant prod-
uct) (∼110 kDa and ∼90 kDa, respectively) was observed (Fig. 1B).
Thus, 3C activity and not a cis acting sequence acts to restrict P1-
2A expression. As a lower 3C activity might be compatible with an
enzyme level sufﬁcient to allow P1-2A expression and subsequent
cleavage, expression cassettes were designed to reduce 3C activ-
ity. Two approaches were used: site-directed mutagenesis of 3C,
based on the three-dimensional structure of the enzyme, that had
previously been shown to reduce enzyme activity in vitro (Sweeney
et al., 2007), and the introduction of the HIV-1 ribosomal frameshift
site, which has been shown to function in insect cells (Adamson
et al., 2003), between the P1-2A and 3C coding sequences (Fig. 1A).
Expression screening revealed that individual changes at 3C residue
142 led to the detection of a band at ∼26 kDa consistent with the
expected molecular weight of the mature VP1 product following 3C
cleavage of the P1-2A precursor protein. A combination of both the
frameshift and the 3C Cys142Thr mutation was  the most produc-
tive approach leading to almost complete processing of P1-2A as
monitored by the appearance of VP1 (Fig. 1B). The serum used for
the Western blot detection of FMDV proteins was  polyvalent but
reactivity was largely directed to epitopes in VP1. However, some
reactivity with intermediates (e.g. VP3-VP1) in the cleavage reac-
tion is apparent. In addition, the resulting optimised vector allows
exchange of the FMDV P1-2A coding region via unique restriction
sites (Fig. 2A) permitting any FMDV capsid serotype to be juxta-
posed to the moderated 3C translation product (Fig. 2B).
A feature of the expression design described here, which dif-
fers from most previous examples, is that only one transcription
unit is present, in this case driven by the AcMNPV p10 promoter
and control of 3C expression is achieved wholly at the level of
translation. Previous examples of high level picornavirus expres-
sion with moderated 3C activity have used different promoters
but exhibited strong host cell variability (Chung et al., 2010). To
assess expression in a variety of insect cells, a high titre bac-
ulovirus stock of the optimal A22 P1-2A-FS-3C-C142T construct
was  used to infect Spodoptera frugiperda (Sf9) and two  Trichoplusia
ni (T.ni and T.nao38) cell lines and a time course of FMDV antigen
expression was  conducted. Sf9 cells are widely used for recom-
binant baculovirus work but T.ni lines have been shown to give
higher expression levels in some cases (Hashimoto et al., 2010,
2012; Maruniak et al., 1994). FMDV VP1 antigen was  apparent at
2 days post infection in all lines tested with peak levels occurring
at 3 and 4 days post infection (Fig. 3A) typical of baculovirus very
late promoter driven expression (Loureiro et al., 2011; Pengelley
et al., 2006). Little unprocessed P1-2A was  observed suggesting
that expression and cleavage are tightly coupled, as expected of
a polyprotein and protease translated from a single mRNA. Both
T.ni cell lines expressed higher levels of FMDV antigen when com-
pared to Sf9 cells on a volume equivalent basis with the rank
order, based on VP1 band intensity, being T.nao38 > T.ni > >Sf9.
Fig. 3. Time course of expression of FMDV A22 antigen in three insect cell lines. Numbers above the track are days post infection in each of the cell lines indicated, with the
exception of track 1 which is the mock infected control. In panel A, the serum used for immunodetection was a Guinea pig polyvalent A serotype (a reagent of the Institute
for  Animal Health). Panel B is an infection control using a monoclonal antibody to the baculovirus surface glycoprotein gp64. Numbers to the left are the migration position
of  protein markers and are in kilodaltons.
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Fig. 4. Analysis of empty capsid assembly. (A) Sucrose gradient fractionation of
FMDV capsid material analysed by Western blot using A22 serotype antisera with an
extract of A22 recombinant virus infectedSf9 cells. Numbers at the top are fractions
numbers. Numbers to the left are the migration position of protein markers and are
in  kilodaltons. (B) Peak fractions from the gradient were analysed by TEM. The bar
is  100 nm.
Differences in signal intensity in the different cell lines did not
relate to levels of baculovirus infection as Western blotting for
a baculovirus encoded protein, the major structural glycoprotein
gp64, showed similar levels of infection (Fig. 3B). In addition, one
commercial cell line, VE cells, in which a viral ankaryn repeat pro-
tein from Campoletis sonorensis ichnovirus has been integrated into
the Sf9 genome to reduce levels of AcMPNV-induced apoptosis
(Fath-Goodin et al., 2009) was tested but they offered no advantage
when compared to unmodiﬁed Sf9 cells (unpublished observa-
tions). Based on the results obtained analogous constructs for the
seven FMDV serotypes should express similarly although further
engineering may  be required to optimise the expression level of
any one sequence.
Cleavage of the FMDV P1-2A precursor protein into mature
structural proteins can lead to empty capsid assembly (Cao et al.,
2009, 2010) although incomplete assembly has also been observed
(Oem et al., 2007). To test for the production of empty capsids in the
system described here, extracts of infected insect cells harvested at
3 days post infection were clariﬁed by low speed centrifugation and
the particulate material present in the supernatant was  collected by
sedimentation through a 30% sucrose cushion and subsequently on
a sucrose velocity gradient. Fractions from the middle of the gradi-
ent (∼40% sucrose), typically the sedimentation position of intact
empty capsids, were positive for VP1 by Western blot (Fig. 4A).
Electron microscopy of the same fractions revealed uniform
structures typical of picornavirus capsids with stain penetration
consistent with empty capsid assembly (Fig. 4B).
To ensure the empty capsids observed were authentic structural
mimics of FMDV particles they were compared with inactivated
FMDV grown in BHK21 cells in a sandwich ELISA format using a
number of interrogating sera (Li et al., 2012). Of 38 different bovine
sera, representing seroconversion to infection or vaccination with
serotype A virus or vaccine, no signiﬁcant differences (P < 0.001)
were observed between the performance of the recombinant empty
capsids and the more established virus antigen source (Fig. 5). These
data suggest that the recombinant empty capsids are faithful mim-
ics of authentic virus, at least to the level probed by the antibodies
used here. Puriﬁed empty FMDV capsids expressed in insect cells
raised neutralising antibodies in guinea-pigs as measured by two
OIE prescribed tests for the presence of speciﬁc antibodies: the virus
neutralisation test (VNT) and the liquid phase blocking ELISA (LPBE)
with the levels of neutralising antibody consistent with protection
in animal models (not shown).
4. Discussion
A new genetic design has been investigated as a robust platform
technology for the efﬁcient production of empty FMDV capsids. Pre-
vious approaches to recombinant picornavirus particle synthesis
in insect cells have included the expression of the complete picor-
naviruses genomes (Brautigam et al., 1993; Rosen et al., 1993) as
well as co-expression of only the structural precursor protein P1
(or P1-2A) and protease, but the levels of capsid obtained have
been variable (Cao et al., 2010; Ko et al., 2005; Li et al., 2008, 2011;
Oem et al., 2007; Roosien et al., 1990). A systematic analysis of the
causes of the observed variation is not available although the lower
pH of insect cell media is not a major factor (Medina et al., 1995).
FMDV 3C enzymes have a reported wide range of cellular targets in
addition to the virus P1-2A structural protein precursor suggesting
that host protein cleavage could occur in insect cells to effectively
curtail expression over the 2–4 days of a baculovirus infection. A
reduced level of 3C was  anticipated to be sufﬁcient to enable P1-
2A cleavage but be insufﬁcient to cause general toxicity. Bicistronic
vectors, in which the 3C coding sequence is transcribed from a less
active promoter have been encouraging but were dependent on
host cell factors (Chung et al., 2010) suggesting that other meth-
ods of translational control, for example through the use of IRES
or frameshift elements (Probst, 2002; Royall et al., 2004) might be
usefully applied. Combining structure-based amino acid substitut-
ions in a ﬂap that folds over the substrate binding pocket of 3C
(Sweeney et al., 2007; Zunszain et al., 2010), with the introduction
of a frameshift signal between the P1-2A and 3C coding regions
designed to lower the level of 3C translated rescued capsid pro-
tein expression. The well characterised HIV-1 frameshift (Dinman,
2012) has a measured -1 shift rate of about ∼1:20 in mammalian
cells suggesting 3C levels would be reduced to 5% of those asso-
ciated with the in-frame P1-2A-3C cassette. However, as the rate
of frameshift in insect cells has not been measured directly, the
actual amount of 3C expression remains to be determined. It is
noteworthy that the -ribbon modiﬁed here was also observed in
other recent 3C enzyme structures (Cui et al., 2011; Lu et al., 2011;
Norder et al., 2011) indicating that similar strategies to reduction
in 3C activity may  be usefully applied to the synthesis of other
picornavirus empty capsids. Similarly, frameshifting rates may  be
altered through modiﬁcation of the “slippery sequence” on which
the ribosome shifts register (Wilson et al., 1988), suggesting fur-
ther optimisation may  be feasible. The expression strategy shown
here for the FMDV A serotype has also been successful for O and
SAT2 serotypes in preliminary experiments (not shown) implying
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Fig. 5. Antigenic characterisation of recombinant FMDV capsids. Comparison of serotype A22 Iraq native antigen and recombinant A22 empty capsids (solid/grey bars) in a
twin  site ELISA with a panel of serum samples. The sera are from animals vaccinated with A Iran05 (1–10), vaccinated and challenged with A24 Cruzeiro (11, 12), vaccinated
and  challenged with A Iran96 (13–18), infected with A22 Iraq 24/64 (19, 20), infected with A24 Cruzeiro (21–24), infected with A Malaysia 97 (25, 26), infected with A Iran99
(27,  28) and vaccinated with A Iran05 (29–38). PI – percentage inhibition.
that the technology may  be generally applicable to all serotypes
and offer a choice of cell line for scale-up. Empty FMDV capsids
were visually uniform by TEM and antigenically indistinguishable
from authentic virus in twin site ELISA. Empty capsids are an
attractive vaccine candidate for FMDV not only because they do
not require high biological containment facilities but also because
they allow modiﬁcation to capsid sequences that would render
infectious virus nonviable. Thus capsid engineering, for example
for improved stability, broadened immune response (Tobin et al.,
2008) or DIVA (Differentiating Infected from Vaccinated Animals)
compliance may  be feasible using the technology described.
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